Product Beschrijving

3-CMC Capsules 220mg

3-CMC Capsules 220mg (also known as clophedrone) is a synthetic cathinone and novel psychoactive substance (NPS) belonging to the substituted cathinone class. It is not approved for any medical use and is sold primarily as a research chemical. A 220mg capsule is considered a very high / heavy dose according to anecdotal reports and available data. Typical reported oral doses range from 20–250mg, with many users describing strong effects above 150–200mg.

Farmacologie

3-CMC acts as a monoamine transporter substrate and releaser. It inhibits the reuptake and promotes the release of dopamine (DA), norepinephrine (NE), and serotonin (5-HT). It has a balanced but potent stimulant profile similar to other chlorinated cathinones like 4-CMC.

• Aanvang (oraal): 15–60 minutes
• Piek: 1-3 uur
• Duur: 3–6 hours (with after-effects lasting longer)

It produces stimulant and empathogenic effects, including euphoria, increased energy, sociability, and elevated heart rate/blood pressure.

Acute veiligheidsprofiel

• Hart-en vaatstelsel: Significant increases in heart rate (tachycardia), blood pressure (hypertension), and risk of chest pain or arrhythmias.
• Neurological / Psychiatric: Agitation, anxiety, paranoia, psychosis, hallucinations, seizures, and psychomotor agitation are commonly reported in intoxications.
• Ander: Hyperthermia (elevated body temperature), sweating, bruxism (teeth grinding), vasoconstriction, tachypnea (rapid breathing), and insomnia.

Animal studies show dose-dependent locomotor stimulation, hypothermia or temperature dysregulation, and sensorimotor alterations at higher doses. Human case reports describe symptoms including aggression, confusion, cardiac issues, and thoracic pain.

Toxicity & Reported Harms

• Multiple non-fatal hospitalizations and at least 10 deaths linked to 3-CMC (reported in Poland and Sweden between 2019–2021), some involving 3-CMC alone.
• High potential for compulsive redosing due to strong cravings, increasing overdose risk.
• Neurotoxiciteit: Suspected dopaminergic and serotonergic toxicity similar to other cathinones (limited direct human data).
• Organ risks: Potential cardiotoxicity, renal strain, and hepatotoxicity with heavy use.

220mg significantly exceeds common recreational doses and raises the likelihood of severe adverse effects, including excited delirium, seizures, or cardiovascular complications.

Geneesmiddelinteracties en contra-indicaties

• Hoog risico: Other stimulants, MDMA, cocaine, alcohol, or MAOIs (increased risk of serotonin syndrome, overheating, or cardiovascular events).
• Strongly contraindicated for individuals with heart conditions, hypertension, anxiety/psychosis history, or mental health disorders.

Product-Related Risks

Unregulated capsules may have inconsistent dosing, purity issues, or contain other substances. Effects can vary widely between batches.

Juridische status (vanaf 2026)

3-CMC is controlled across the European Union, UK (Class B), and many other countries. It is banned or heavily restricted in most jurisdictions worldwide due to its harm potential.

Belangrijke Opmerking: This is a neutral, educational overview based on available scientific reports, risk assessments (EMCDDA, WHO), and case data. There are very limited clinical safety studies on 3-CMC in humans, and significant uncertainties remain regarding both short- and long-term risks. This information does niet encourage use. Synthetic cathinones like 3-CMC carry substantial potential for harm, dependence, and acute toxicity. Consult a qualified healthcare professional for any health concerns and comply with all local laws.

Aanvullende Informatie